Jenny Qian - Xenon Pharmaceuticals Inc

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Azetukalner, a Novel KV7 Potassium Channel Opener, in Adults with Major Depressive Disorder: A Randomized Clinical Trial

Noam N Butterfield,Constanza Luzon Rosenblut,Maurizio Fava, Christoph U Correll, Anthony J Rothschild, James W Murrough, Sanjay J Mathew, Gregory N Beatch,Celene Grayson, Cynthia Harden,Jenny Qian, Joe McIntosh, Rostam Namdari,Christopher Kenney

JAMA network openno. 5 (2025): e2514278-e2514278

引用0浏览0WOS引用

Interim Analysis of the Long-Term Efficacy and Safety of Azetukalner in an Ongoing Open-Label Extension Study Following a Phase 2b Clinical Trial (X-TOLE) in Adults with Focal Epilepsy

Jacqueline A French,Roger J Porter,Emilio Perucca, Martin J Brodie,Michael A Rogawski,Cynthia Harden,Jenny Qian,Constanza Luzon Rosenblut,Christopher Kenney, Gregory N Beatch, X‐TOLE Study Group

Epilepsia openno. 2 (2025): 539-548

引用0浏览0WOS引用

The Impact of Disease Severity on Responder Rates in a Phase 2b Study of XEN1101, a Potent, Selective Potassium Channel Opener, in Adults with Focal Epilepsy (X-TOLE) (S19.004)

Roger Porter,Jacqueline French,Emilio Perucca,Martin Brodie,Cynthia Harden,Constanza Luzon Rosenblut,Jenny Qian,Christopher Kenney,Gregory Beatch

Neurologyno. 17_supplement_1 (2024)

引用0浏览0引用

Interim Long-term Safety and Efficacy of XEN1101, a Potent, Selective Potassium Channel Opener: Update from an Ongoing Open-label Extension of a Phase 2b Study (X-TOLE) in Adults with Focal Epilepsy (S19.005)

Jacqueline French,Roger Porter,Emilio Perucca,Martin Brodie,Michael Rogawski,Cynthia Harden,Jenny Qian,Constanza Luzon Rosenblut,Christopher Kenney,Gregory Beatch

Neurology（2024）

引用0浏览0引用

Quality- of- life improvements in adults with focal onset seizures treated with XEN1101 in an ongoing, long-term, open-label extension of a phase 2b study (X-TOLE)

C. Brandt,V. Villanueva,C. Harden,J. Qian, C. Luzon-Rosenblut, J. Wagner,C. Kenney,G. N. Beatch

EPILEPSIA (2023): 276-276

引用0浏览0引用

Design of Two Parallel Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies to Evaluate the Safety and Efficacy of XEN1101 As Adjunctive Therapy in the Treatment of Focal Onset Epilepsy

E. Perucca,J. French,E. Ben-Menachem, D. Gloss,W. C. LaFrance,P. Ryvlin,M. Sazgar,M. Toledo,T. Tomson,E. Trinka,V. Villanueva, R. Wechsler,C. Harden,J. Qian, C. Luzon-Rosenblut,C. Kenney,G. N. Beatch

EPILEPSIA（2023）

引用0浏览0引用

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults with Focal Epilepsy: A Phase 2b Randomized Clinical Trial

Jacqueline A French,Roger J Porter,Emilio Perucca,Martin J Brodie,Michael A Rogawski,Simon Pimstone,Ernesto Aycardi,Cynthia Harden,Jenny Qian,Constanza Luzon Rosenblut,Christopher Kenney,Gregory N Beatch, X-TOLE Study Group

JAMA neurology（2023）

引用0浏览0WOS引用

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of XEN1101 As an Adjunctive Therapy in the Treatment of Primary Generalized Tonic-Clonic Seizures

A. Gil-Nagel Rein,D. Vossler,E. Ben-Menachem,W. C. LaFrance,C. Harden,J. Qian,G. N. Beatch,C. Kenney

EPILEPSIA (2023): 17-18

引用0浏览0引用

XEN1101, a Novel Potassium Channel Modulator: Interim Data from an Ongoing, Long-Term, Open-Label Extension of a Phase 2b Study (X-TOLE) in Adults with Focal Epilepsy

J. French,R. Porter,E. Perucca,M. Brodie,M. A. Rogawski,C. Harden,J. Qian,C. Luzon-Rosenblut,C. Kenney,G. N. Beatch

EPILEPSIA（2023）

引用1浏览0引用

XEN1101, a Novel Potassium Channel Modulator: Interim Data from an Ongoing, Long-Term, Open-Label Extension of a Phase 2b Study (X-TOLE) in Adults with Focal Epilepsy (S44.008)

Jacqueline French,Roger Porter,Emilio Perucca,Martin Brodie,Michael Rogawski,Cynthia Harden,Jenny Qian,Constanza Luzon-Rosenblut,Christopher Kenney,Gregory Beatch

Neurology（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn